Spondyloarthritis & psoriatic arthritis

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis

Arthritis Res TherPublished Diagnostic biomarker discovery study

Authors' conclusion

We identified multiple candidate AS diagnostic and disease activity monitoring serum biomarkers using a comprehensive proteomic screen. Enrichment analysis identified key pathways in AS diagnosis and monitoring. Lasso regression identified a multi-protein panel with modest predictive ability.

Study context

Population
Biologic-treatment-naïve ankylosing spondylitis (AS) patients and healthy control (HC)
Participants
80 serum samples
Comparison
AS vs HC; high vs low disease activity
Outcome
Differentially expressed serum proteins for AS diagnosis (AS vs HC) and disease activity monitoring (high vs low)
Methodological detailsproteomic screen (SOMAscan aptamer-based platform), matched by age, gender and race (1:1:1), Lasso regression
  • Proteomic screen (SOMAscan aptamer-based platform)
  • Matched by age, gender and race (1:1:1)
  • Lasso regression

Performance

As reported in the abstract

Proteins detected
1317
Diagnosis differentially expressed proteins (DEPs) (FDR q < .05: 317)
367
Monitoring DEPs (FDR q < .05: 59)
167
13-protein model sensitivity
0.75
13-protein model specificity
0.90
13-protein model kappa
0.59
13-protein model overall accuracy
0.80 (95% CI 0.61-0.92)
AS vs HC ROC
0.79 (95% CI 0.61-0.96)

Further findings

Top PPI clusters (Molecular Complex Detection (MCODE)) and Ingenuity Pathway Analysis (IPA) upstream regulators

Top 3 diagnosis clusters: complement, IL-10 signaling, immune/IL signaling
Top 3 monitoring clusters: complement, extracellular matrix organization/proteoglycans, MAPK/RAS signaling
Predicted upstream regulators: IL-23/17, TNF, cGAS-STING and Jak/Stat signaling

Original publication

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis. Arthritis Res Ther. Published 11 April 2023. doi:10.1186/s13075-023-03044-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.